Low vs standard dose of remimazolam for calm wake-up after nasal surgery
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study compares a low dose versus a standard dose of the sedative remimazolam to prevent confusion or agitation after waking up from nasal surgery. It aims to find a safer, more comfortable recovery for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 79 years old.
- You are scheduled for nasal surgery under general anesthesia (using sevoflurane).
- You are not allergic to benzodiazepine drugs (like Valium or Xanax).
- You do not have a current psychiatric disorder or a history of alcohol/drug abuse.
- Your body mass index (BMI) is 40 or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of anesthesia used during nasal surgery to see if one causes less confusion or restlessness when waking up. If you are having nasal surgery with general anesthesia, this trial may help find a gentler way to recover from anesthesia.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This study tests if a sedative called remimazolam can help you sleep better after a short surgery. Volunteers must be generally healthy, have a normal weight, and not have current sleep disorders.
This study tests a medicine called remimazolam to see if it reduces confusion and agitation (emergence delirium) when children wake up from brain surgery. It may help your child have a smoother recovery.
This study tests whether a combination of two medicines (esketamine and remimazolam) can help people sleep better and feel less anxious after surgery. Researchers want to see if this approach works better than standard care.
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
Hear when a new Emergence Agitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.